PWA
GILD icon

Principia Wealth Advisory’s Gilead Sciences GILD Stock Holding History

Principia Wealth Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Buy
114
+23
+25% +$3.03K 0.01% 206
2026
Q1 		$12.7K Buy
91
+16
+21% +$2.24K 0.01% 193
2025
Q4 		$9.21K Buy
75
+9
+14% +$1.09K 0.01% 209
2025
Q3 		$7.33K Buy
66
+6
+10% +$682 0.01% 231
2025
Q2 		$6.65K Buy
60
+13
+28% +$1.38K 0.01% 206
2025
Q1 		$4.95K Buy
47
+12
+34% +$1.24K ﹤0.01% 177
2024
Q4 		$3.23K Buy
+35
New +$3.15K ﹤0.01% 185

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Principia Wealth Advisory's GILD Position: Q2 2026 in Review

Principia Wealth Advisory increased its Gilead Sciences (GILD) stake by 25% in Q2 2026, buying an estimated $3.03K and bringing the position to 114 shares worth $14.4K. The position accounts for 0.01% of the portfolio, ranked #206.

Principia Wealth Advisory first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Principia Wealth Advisory held 114 shares of Gilead Sciences worth $14.4K as of Q2 2026.
  • Principia Wealth Advisory bought 23 Gilead Sciences shares in Q2 2026, an estimated $3.03K.
  • Gilead Sciences made up 0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #206 holding.
  • Principia Wealth Advisory first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.